Cognition Therapeutics, Inc.
CGTX
$1.01
-$0.03-2.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 41.61% | 46.11% | 57.37% | 50.39% | 4.36% |
| Total Depreciation and Amortization | -9.84% | 51.11% | -14.08% | -12.86% | -8.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -52.01% | -42.83% | -25.28% | -41.74% | -45.86% |
| Change in Net Operating Assets | 22.61% | 32.20% | 51.62% | -161.51% | 352.35% |
| Cash from Operations | 45.71% | 43.89% | 59.00% | 17.52% | 6.24% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 1,000.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 3.33% | 4.24% | 62.05% | 77.84% | 33.70% |
| Issuance of Common Stock | 668.19% | -96.99% | -76.75% | -- | -37.09% |
| Repurchase of Common Stock | -120.00% | -256.52% | -- | 95.58% | 77.27% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -68.92% | -- | -- |
| Cash from Financing | 778.99% | -117.98% | -94.68% | 10,209.12% | 644.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 172.61% | 32.70% | -194.16% | 533.39% | 20.64% |